Blue Water Biotech Profit Margin

The latest profit margin for BWV is -1319.55% as of March 2026. That compares with -2357.04% in the prior-year period — up 44.0% year over year. That is below the sector sector average of 19.74%. Investors often review this figure alongside Blue Water Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, BWV's profit margin moved from -2357.04% to -1319.55% — a 44.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Blue Water Biotech's valuation or profitability profile.

Against its sector companies, BWV currently prints -1319.55% for profit margin, while the sector average sits near 19.74%. That is roughly 6785.1% below the sector mean. Large gaps often invite a closer look at Blue Water Biotech's growth, margins, and balance sheet.

Profit Margin shows how effectively Blue Water Biotech converts resources into returns. At -1319.55%, BWV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2357.04% in the prior-year period — up 44.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BWV's profit margin (-1319.55%), review year-over-year change from -2357.04%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.